4340 Duncan Avenue St. Louis, MO 63110 314-615-6355 info@biogenerator.org


BioGenerator News

BioGenerator Company Benson Hill Biosystems Raises $60 Million Series C led by GV

Sep 10, 2018

BioGenerator portfolio company Benson Hill Biosystems, a crop improvement company unlocking the natural genetic diversity of plants, today announced the first close of its $60 million Series C financing.  BioGenerator was […]

Read More

BioGenerator Company BlueStrata EHR Acquired by Mediware

Aug 01, 2018

BioAcquisition expands Mediware’s solutions to include software for skilled nursing and assisted living facilities and offers BlueStrata EHR expanded resources for investments in innovation and sales. Mediware Information Systems, Inc., […]

Read More

$100 million Confluence deal is good exit for BioGenerator

May 24, 2018

Following Pfizer’s announcement to cut 600 of its 1,000 St. Louis-area jobs in 2009, several Pfizer executives, including Joe Monahan and Walter Smith, faced a difficult decision. They could relocate […]

Read More

BioGenerator and Kingdom Capital Lead $2.4 Million Series A Venture Capital Financing for Canopy Biosciences

May 22, 2018

Startup to Advance Research Tools Development and Add Jobs ST. LOUIS – Canopy Biosciences has exceeded its Series A financing goal, closing a $2.4 million investment to develop new research […]

Read More

BacterioScan, a BioGenerator portfolio company, secures FDA clearance – UTI detection in hours, not days

May 14, 2018

St. Louis, May 14, 2018 – BacterioScan, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a 510(k) Premarket Notification clearance for its 216Dx Urinary Tract […]

Read More

BioGenerator Company RNAgri Inks Deal with Monsanto for Use of RNA Production Technology

Apr 04, 2018

BioGenerator-backed AgTech Company Focuses on Naturally-Occurring Process ST. LOUIS – RNAgri, a St. Louis startup developing technology for agriculture, has entered a research collaboration with global agriculture company Monsanto. The […]

Read More

St. Louis-based Unleash Immuno Oncolytics Attracts $3 Million Investment from Publicly-traded Japanese Company

Feb 19, 2018

BioGenerator-supported Company to Advance Cancer Therapies ST. LOUIS – St. Louis-based startup Unleash Immuno Oncolytics, which has developed viral-based biologics to attack cancerous tumors, has attracted a major investment from […]

Read More

SentiAR Awarded $2.2 Million Federal Grant to Advance Augmented Reality Cardiac Hologram Research

Feb 12, 2018

ST. LOUIS – A panel of cardiologists, engineers, and other experts have given SentiAR, Inc.’s augmented reality (AR) platform an exceptional peer review, leading the National Institutes for Health (NIH) […]

Read More

BioGenerator Wins Federal Grant to Build New St. Louis Bioscience Companies

Sep 26, 2017

ST. LOUIS – BioGenerator, the investment arm of BioSTL, has won a $300,000 grant from the U.S. Department of Commerce to capitalize on its retooled investment strategy. That strategy is […]

Read More

BioGenerator supported startup Disarm Therapeutics announces $30M financing

Sep 19, 2017

BioGenerator supported startup company Disarm Therapeutics has closed a $30M financing led by top tier venture funds including Atlas Ventures. Prior to the company being formed, BioGenerator supported the academic […]

Read More

Latest Tweets

Getting Started

Entrepreneurs Investors